奥马珠单抗和美泊利单抗联合治疗难治性变应性支气管肺曲霉病 - Suppr

Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.

作者信息

Altman Matthew C, Lenington Jake, Bronson Steve, Ayars Andrew G

机构信息

University of Washington Medical Center, Seattle, Wash; Center for Allergy and Inflammation, UW Medicine at South Lake Union, Seattle, Wash.

University of Washington Medical Center, Seattle, Wash.

出版信息

J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1137-1139. doi: 10.1016/j.jaip.2017.01.013. Epub 2017 Mar 6.

DOI:10.1016/j.jaip.2017.01.013

PMID:28279664

Abstract

摘要

相似文献

Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.

J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1137-1139. doi: 10.1016/j.jaip.2017.01.013. Epub 2017 Mar 6.

Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.

J Investig Allergol Clin Immunol. 2020;30(5):378-379. doi: 10.18176/jiaci.0564. Epub 2020 May 6.

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

Cochrane Database Syst Rev. 2015 Nov 4(11):CD010288. doi: 10.1002/14651858.CD010288.pub3.

Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.

Pediatr Pulmonol. 2017 Feb;52(2):190-197. doi: 10.1002/ppul.23612. Epub 2016 Oct 7.

Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):111-3. doi: 10.1016/j.jaip.2013.08.014. Epub 2013 Oct 19.

Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.

Respir Med. 2017 Dec;133:12-15. doi: 10.1016/j.rmed.2017.11.007. Epub 2017 Nov 10.

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD010288. doi: 10.1002/14651858.CD010288.pub4.

Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.

Ann Allergy Asthma Immunol. 2015 Sep;115(3):250-1. doi: 10.1016/j.anai.2015.06.014. Epub 2015 Jul 7.

A case of allergic bronchopulmonary aspergillosis treated with omalizumab.

J Investig Allergol Clin Immunol. 2012;22(2):145-7.

[Biological Treatments in patients with ABPA].

Tuberk Toraks. 2021 Mar;69(1):84-93. doi: 10.5578/tt.20219910.

引用本文的文献

Duo biologic therapy using mepolizumab and omalizumab in refractory ABPA: two cases.

Allergy Asthma Clin Immunol. 2025 Sep 2;21(1):39. doi: 10.1186/s13223-025-00985-0.

Treatment of allergic bronchopulmonary aspergillosis with biologics.

Chin Med J Pulm Crit Care Med. 2025 Jan 10;3(1):6-11. doi: 10.1016/j.pccm.2024.11.005. eCollection 2025 Mar.

Dual biological treatments in immune-mediated disorders: a single center experience.

BMC Immunol. 2025 Apr 8;26(1):29. doi: 10.1186/s12865-025-00705-8.

Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways.

Immunol Rev. 2024 Nov;328(1):387-411. doi: 10.1111/imr.13380. Epub 2024 Aug 19.

Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship.

Cureus. 2024 Apr 9;16(4):e57917. doi: 10.7759/cureus.57917. eCollection 2024 Apr.

Dual biologics for severe asthma and atopic dermatitis: Synopsis of two cases and literature review.

Respirol Case Rep. 2023 Dec 6;12(1):e01266. doi: 10.1002/rcr2.1266. eCollection 2024 Jan.

Combination of Biological Therapy in Severe Asthma: Where We Are?

J Pers Med. 2023 Nov 10;13(11):1594. doi: 10.3390/jpm13111594.

GEMA 5.3. Spanish Guideline on the Management of Asthma.

Open Respir Arch. 2023 Sep 19;5(4):100277. doi: 10.1016/j.opresp.2023.100277. eCollection 2023 Oct-Dec.

Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection.

Respir Med Case Rep. 2023 Jul 16;45:101890. doi: 10.1016/j.rmcr.2023.101890. eCollection 2023.

Specific Therapy for T2 Asthma.

J Pers Med. 2022 Apr 7;12(4):593. doi: 10.3390/jpm12040593.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.

J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1137-1139. doi: 10.1016/j.jaip.2017.01.013. Epub 2017 Mar 6.

Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.

J Investig Allergol Clin Immunol. 2020;30(5):378-379. doi: 10.18176/jiaci.0564. Epub 2020 May 6.

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

Cochrane Database Syst Rev. 2015 Nov 4(11):CD010288. doi: 10.1002/14651858.CD010288.pub3.

Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.

Pediatr Pulmonol. 2017 Feb;52(2):190-197. doi: 10.1002/ppul.23612. Epub 2016 Oct 7.

Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):111-3. doi: 10.1016/j.jaip.2013.08.014. Epub 2013 Oct 19.

Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.

Respir Med. 2017 Dec;133:12-15. doi: 10.1016/j.rmed.2017.11.007. Epub 2017 Nov 10.

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

Cochrane Database Syst Rev. 2018 Mar 18;3(3):CD010288. doi: 10.1002/14651858.CD010288.pub4.

Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.

Ann Allergy Asthma Immunol. 2015 Sep;115(3):250-1. doi: 10.1016/j.anai.2015.06.014. Epub 2015 Jul 7.

A case of allergic bronchopulmonary aspergillosis treated with omalizumab.

J Investig Allergol Clin Immunol. 2012;22(2):145-7.

[Biological Treatments in patients with ABPA].

Tuberk Toraks. 2021 Mar;69(1):84-93. doi: 10.5578/tt.20219910.

引用本文的文献

Duo biologic therapy using mepolizumab and omalizumab in refractory ABPA: two cases.

Allergy Asthma Clin Immunol. 2025 Sep 2;21(1):39. doi: 10.1186/s13223-025-00985-0.

Treatment of allergic bronchopulmonary aspergillosis with biologics.

Chin Med J Pulm Crit Care Med. 2025 Jan 10;3(1):6-11. doi: 10.1016/j.pccm.2024.11.005. eCollection 2025 Mar.

Dual biological treatments in immune-mediated disorders: a single center experience.

BMC Immunol. 2025 Apr 8;26(1):29. doi: 10.1186/s12865-025-00705-8.

Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways.

Immunol Rev. 2024 Nov;328(1):387-411. doi: 10.1111/imr.13380. Epub 2024 Aug 19.

Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship.

Cureus. 2024 Apr 9;16(4):e57917. doi: 10.7759/cureus.57917. eCollection 2024 Apr.

Dual biologics for severe asthma and atopic dermatitis: Synopsis of two cases and literature review.

Respirol Case Rep. 2023 Dec 6;12(1):e01266. doi: 10.1002/rcr2.1266. eCollection 2024 Jan.

Combination of Biological Therapy in Severe Asthma: Where We Are?

J Pers Med. 2023 Nov 10;13(11):1594. doi: 10.3390/jpm13111594.

GEMA 5.3. Spanish Guideline on the Management of Asthma.

Open Respir Arch. 2023 Sep 19;5(4):100277. doi: 10.1016/j.opresp.2023.100277. eCollection 2023 Oct-Dec.

Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection.

Respir Med Case Rep. 2023 Jul 16;45:101890. doi: 10.1016/j.rmcr.2023.101890. eCollection 2023.

Specific Therapy for T2 Asthma.

J Pers Med. 2022 Apr 7;12(4):593. doi: 10.3390/jpm12040593.

Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献